@WHO: WHO has also called for technology transfer to allow for the manufacturing of biosimilar versions around the 🌍 so all patients who may need this treatment have access to it. https://t.co/dXmYDVb7Mi https://t.co/R1CgbCGR85

http://twitter.com/WHO
via IFTTT